Therapieoptionen bei Weight-Regain nach Bariatrischer Operation

Alida Finze; Mirko Otto; Christoph Reissfelder; Susanne Blank

doi:10.1055/a-1957-5570

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000104.xml

Share / Bookmark

Facebook Twitter Linkedin Weibo

Download PDF

Zentralbl Chir 2022; 147(06): 547-555
DOI: 10.1055/a-1957-5570

Übersicht

Therapieoptionen bei Weight-Regain nach Bariatrischer Operation

Therapeutic Options for Regaining Weight after Bariatric Surgery

Alida Finze

¹Chirurgische Klinik, Universitätsklinikum Mannheim, Mannheim, Deutschland (Ringgold ID: RIN36642)

,

Mirko Otto

¹Chirurgische Klinik, Universitätsklinikum Mannheim, Mannheim, Deutschland (Ringgold ID: RIN36642)

,

Christoph Reissfelder

¹Chirurgische Klinik, Universitätsklinikum Mannheim, Mannheim, Deutschland (Ringgold ID: RIN36642)

,

Susanne Blank

¹Chirurgische Klinik, Universitätsklinikum Mannheim, Mannheim, Deutschland (Ringgold ID: RIN36642)

› Author Affiliations

› Further Information

Also available at

Abstract
Full Text
References

Permissions and Reprints

Zusammenfassung

Hintergrund Die Intention dieses Artikels ist, einen Überblick über die Diagnosestellung und Therapiemöglichkeiten bei erneuter Gewichtszunahme (WR) oder unzureichendem Gewichtsverlust (IWL) nach bariatrischer Operation (BS) zu geben. Bei weiter steigenden Zahlen der BS gewinnt WR immer mehr an Relevanz.

Methoden Eine ausgiebige Literaturrecherche wurde mit persönlichen Erfahrungen kombiniert, um eine mögliche Handlungsempfehlung bei WR oder IWL zu geben.

Ergebnisse Im Falle einer anatomischen Ursache für WR ist der chirurgische Therapieansatz derzeit am effektivsten. Bei idiopathischem WR oder IWL ist ein multimodales Therapiekonzept für eine erfolgreiche Therapie notwendig. Abhängig von der vorangegangenen OP ist eine Kombination von Lebensstilinterventionen, medikamentöser und chirurgischer Therapie ein wirksames Vorgehen.

Schlussfolgerungen Eine ausgiebige Diagnostik ist vor Indikationsstellung einer chirurgischen Revision notwendig. Bei idiopathischem WR und IWL nach Roux-Y-Magenbypass (RYGB) schlagen wir die Verlängerung des biliopankreatischen Schenkels bei gleichzeitiger Verkürzung des Common Channels vor. Nach Schlauchmagen (Sleeve-Gastrektomie, SG) sehen wir derzeit die Umwandlung in RYGB bei Patienten mit gleichzeitiger Refluxösophagitis und den SADI-S bei fehlendem Vorliegen eines Refluxes als sinnvollste Therapie an.

Abstract

Purpose The purpose of this article is to create an overview of diagnostic and therapeutic options for weight regain (WR) and insufficient weight loss (IWL) after bariatric surgery (BS). With increasing popularity of BS, WR is becoming more relevant.

Methods We combined recent literature on WR and IWL with personal experience to suggest possible proceedings if WR or IWL is diagnosed.

Results If an anatomical-pathological cause can be detected, surgical therapy is the most effective. If WR or IWL is idiopathic, a multimodal therapeutic concept is necessary for sufficient therapeutic success. Depending on the initial BS, a combination of lifestyle intervention, medication and surgical therapy seems most effective.

Conclusions Extensive diagnostic testing is necessary prior to any surgical intervention. In idiopathic WR after Roux-en-Y Gastric Bypass (RYGB), we suggest lengthening the biliopancreatic limb and shortening the common channel. After Sleeve-Gastrectomy (SG), we currently see RYGB as most effective in patients with gastroesophageal reflux disease (GERD) and SADI-S as a feasible option if no GERD is present.

Schlüsselwörter

Schlauchmagen - Roux-Y Magenbypass - OAGB - Gewichtszunahme - SADI

Keywords

RYGB - sleeve gastrectomy - OAGB - insufficient weight loss - SADI

Publication History

Received: 07 June 2022

Accepted after revision: 08 September 2022

Article published online:
07 December 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Literatur
1 Brown WA, Kow L, Shikora S, Liem L, Welbourn R, Dixon J, Walton P, Kinsman R. 6th IFSO Global Registry Report 2021. The IFSO Global Registry 2021. Accessed October 17, 2022 at: https://www.ifso.com/pdf/ifso-6th-registry-report-2021.pdf
2 American Society for Metabolic and Bariatric Surgery. Estimate of Bariatric Surgery Numbers, 2011–2020. In: American Society for Metabolic and Bariatric Surgery 2022 Accessed October 26, 2022 at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers
3 Buchwald H, Avidor Y, Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737 DOI: 10.1001/jama.292.14.1724.
4 Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 14: 160-169 DOI: 10.1038/nrgastro.2016.170.
5 Arterburn DE, Johnson E, Coleman KJ. et al. Weight Outcomes of Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Treatment. Ann Surg 2021; 274: e1269-e1276 DOI: 10.1097/SLA.0000000000003826.
6 Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc 2017; 31: 4331-4345 DOI: 10.1007/s00464-017-5505-1.
7 Wolnerhanssen BK, Peterli R, Hurme S. et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS). Br J Surg 2021; 108: 49-57 DOI: 10.1093/bjs/znaa011.
8 El Ansari W, Elhag W. Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review. Obes Surg 2021; 31: 1755-1766 DOI: 10.1007/s11695-020-05160-5.
9 Clapp B, Wynn M, Martyn C. et al. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis 2018; 14: 741-747 DOI: 10.1016/j.soard.2018.02.027.
10 Sjöström L, Lindroos AK, Peltonen M. et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N Engl J Med 2004; 351: 2683-2693 DOI: 10.1056/NEJMoa035622.
11 Courcoulas AP, King WC, Belle SH. et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg 2018; 153: 427-434 DOI: 10.1001/jamasurg.2017.5025.
12 Maciejewski ML, Arterburn DE, Van Scoyoc L. et al. Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg 2016; 151: 1046-1055 DOI: 10.1001/jamasurg.2016.2317.
13 King WC, Hinerman AS, Belle SH. et al. Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association with Clinical Outcomes. JAMA 2018; 320: 1560-1569 DOI: 10.1001/jama.2018.14433.
14 Borbely Y, Winkler C, Kroll D. et al. Pouch Reshaping for Significant Weight Regain after Roux-en-Y Gastric Bypass. Obes Surg 2017; 27: 439-444 DOI: 10.1007/s11695-016-2329-3.
15 Athanasiadis DI, Martin A, Kapsampelis P. et al. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc 2021; 35: 4069-4084 DOI: 10.1007/s00464-021-08329-w.
16 Karmali S, Brar B, Shi X. et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg 2013; 23: 1922-1933 DOI: 10.1007/s11695-013-1070-4.
17 Istfan NW, Lipartia M, Anderson WA. et al. Approach to the Patient: Management of the Post-Bariatric Surgery Patient With Weight Regain. J Clin Endocrinol Metab 2021; 106: 251-263 DOI: 10.1210/clinem/dgaa702.
18 Dar R, Dola T, Sakran N. Laparoscopic Conversion of Sleeve Gastrectomy to One Anastomosis Gastric Bypass Due to Unresected Fundus and Weight Regain: Technical Considerations. Obes Surg 2020; 30: 3647-3649 DOI: 10.1007/s11695-020-04785-w.
19 Lauti M, Kularatna M, Hill AG. et al. Weight Regain Following Sleeve Gastrectomy-a Systematic Review. Obes Surg 2016; 26: 1326-1334 DOI: 10.1007/s11695-016-2152-x.
20 Le Roux CW, Welbourn R, Werling M. et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780-785 DOI: 10.1097/SLA.0b013e3180caa3e3.
21 Romagna EC, Lopes KG, Mattos DMF. et al. Physical Activity Level, Sedentary Time, and Weight Regain After Bariatric Surgery in Patients Without Regular Medical Follow-up: a Cross-Sectional Study. Obes Surg 2021; 31: 1705-1713 DOI: 10.1007/s11695-020-05184-x.
22 Mauro M, Papelbaum M, Brasil MAA. et al. Is weight regain after bariatric surgery associated with psychiatric comorbidity? A systematic review and meta-analysis. Obes Rev 2019; 20: 1413-1425 DOI: 10.1111/obr.12907.
23 Odom J, Zalesin KC, Washington TL. et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg 2010; 20: 349-356 DOI: 10.1007/s11695-009-9895-6.
24 Velapati SR, Shah M, Kuchkuntla AR. et al. Weight Regain After Bariatric Surgery: Prevalence, Etiology, and Treatment. Curr Nutr Rep 2018; 7: 329-334 DOI: 10.1007/s13668-018-0243-0.
25 Brethauer SA, Nfonsam V, Sherman V. et al. Endoscopy and upper gastrointestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery. Surg Obes Relat Dis 2006; 2: 643-648 DOI: 10.1016/j.soard.2006.07.012.
26 D’Hondt M, Vansteenkiste F, Van Rooy F. et al. Gastrogastric Fistula after Gastric Bypass – Is Surgery Always Needed?. Obes Surg 2006; 16: 1548-1551 DOI: 10.1381/096089206778870076.
27 Corcelles R, Jamal MH, Daigle CR. et al. Surgical management of gastrogastric fistula. Surg Obes Relat Dis 2015; 11: 1227-1232 DOI: 10.1016/j.soard.2015.03.004.
28 Arnoldner MA, Felsenreich DM, Langer FB. et al. Pouch volume and pouch migration after Roux-en-Y gastric bypass: a comparison of gastroscopy and 3 D-CT volumetry: is there a „migration crisis“?. Surg Obes Relat Dis 2020; 16: 1902-1908 DOI: 10.1016/j.soard.2020.07.024.
29 Alva S, Eisenberg D, Duffy A. et al. Virtual three-dimensional computed tomography assessment of the gastric pouch following laparoscopic Roux-Y gastric bypass. Obes Surg 2008; 18: 364-366 DOI: 10.1007/s11695-008-9438-6.
30 Srivastava G, Buffington C. A Specialized Medical Management Program to Address Post-operative Weight Regain in Bariatric Patients. Obes Surg 2018; 28: 2241-2246 DOI: 10.1007/s11695-018-3141-z.
31 Miras AD, Pérez-Pevida B, Aldhwayan M. et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2019; 7: 549-559 DOI: 10.1016/s2213-8587(19)30157-3.
32 Redmond IP, Shukla AP, Aronne LJ. Use of Weight Loss Medications in Patients after Bariatric Surgery. Curr Obes Rep 2021; 10: 81-89 DOI: 10.1007/s13679-021-00425-1.
33 Horber FF, Steffen R. Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study. Obes Surg 2021; 31: 93-100 DOI: 10.1007/s11695-020-04856-y.
34 Wharton S, Kuk JL, Luszczynski M. et al. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery. Clin Obes 2019; 9: e12323 DOI: 10.1111/cob.12323.
35 Suliman M, Buckley A, Al Tikriti A. et al. Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients. Diabetes Obes Metab 2019; 21: 1498-1501 DOI: 10.1111/dom.13672.
36 O’Neil PM, Birkenfeld AL, McGowan B. et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet 2018; 392: 637-649 DOI: 10.1016/s0140-6736(18)31773-2.
37 Clément K, van den Akker E, Argente J. et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol 2020; 8: 960-970 DOI: 10.1016/s2213-8587(20)30364-8.
38 Lau DCW, Erichsen L, Francisco AM. et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 2021; 398: 2160-2172 DOI: 10.1016/s0140-6736(21)01751-7.
39 Enebo LB, Berthelsen KK, Kankam M. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet 2021; 397: 1736-1748 DOI: 10.1016/s0140-6736(21)00845-x.
40 Frias JP, Davies MJ, Rosenstock J. et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med 2021; 385: 503-515 DOI: 10.1056/NEJMoa2107519.
41 Goh YM, James NE, Goh EL. et al. The use of endoluminal techniques in the revision of primary bariatric surgery procedures: a systematic review. Surg Endosc 2020; 34: 2410-2428 DOI: 10.1007/s00464-020-07468-w.
42 Pasquer A, Pelascini E, Poncet G. et al. Laparoscopic Treatment of Gastro-Gastric Fistula After RYGB: Technical Points. Obes Surg 2018; 28: 1452-1453 DOI: 10.1007/s11695-018-3164-5.
43 Franken RJ, Sluiter NR, Franken J. et al. Treatment Options for Weight Regain or Insufficient Weight Loss After Sleeve Gastrectomy: a Systematic Review and Meta-analysis. Obes Surg 2022; 32: 2035-2046 DOI: 10.1007/s11695-022-06020-0.
44 Saliba C, El Rayes J, Diab S. et al. Weight Regain After Sleeve Gastrectomy: A Look at the Benefits of Re-sleeve. Cureus 2018; 10: e3450 DOI: 10.7759/cureus.3450.
45 Cesana G, Uccelli M, Ciccarese F. et al. Laparoscopic re-sleeve gastrectomy as a treatment of weight regain after sleeve gastrectomy. World J Gastrointest Surg 2014; 6: 101-106 DOI: 10.4240/wjgs.v6.i6.101.
46 Omarov T, Samadov E, Bayramov N. et al. The Effectiveness and Feasibility of Laparoscopic Re-sleeve Gastrectomy. Obes Surg 2020; 30: 4945-4952 DOI: 10.1007/s11695-020-04927-0.
47 AlSabah S, Alsharqawi N, Almulla A. et al. Approach to Poor Weight Loss After Laparoscopic Sleeve Gastrectomy: Re-sleeve Vs. Gastric Bypass. Obes Surg 2016; 26: 2302-2307 DOI: 10.1007/s11695-016-2119-y.
48 Amor IB, Petrucciani N, Kassir R. et al. Midterm Outcomes of Gastric Pouch Resizing for Weight Regain After Roux-en-Y Gastric Bypass. Obes Surg 2020; 30: 2723-2728 DOI: 10.1007/s11695-020-04560-x.
49 Boerboom A, Aarts E, Lange V. et al. Banding the Pouch with a Non-adjustable Ring as Revisional Procedure in Patients with Insufficient Results After Roux-en-Y Gastric Bypass: Short-term Outcomes of a Multicenter Cohort Study. Obes Surg 2020; 30: 797-803 DOI: 10.1007/s11695-019-04361-x.
50 Jacobs K, Vleeschouwers W, Debergh I. et al. Laparoscopic Adjustable Gastric Banding with the Adhesix(R) Bioring(R) for Weight Regain or Insufficient Weight Loss After a Roux-en-Y Gastric Bypass: Midterm Data from the Pronto Registry. Obes Surg 2021; 31: 4295-4304 DOI: 10.1007/s11695-021-05537-0.
51 Uittenbogaart M, Leclercq WK, Luijten AA. et al. Laparoscopic Adjustable Gastric Banding After Failed Roux-En-Y Gastric Bypass. Obes Surg 2017; 27: 381-386 DOI: 10.1007/s11695-016-2283-0.
52 Yeo C, Ho G, Syn N. et al. Revisional One-Anastomosis Gastric Bypass After Restrictive Index Surgery-a Metaanalysis and Comparison with Revisional Roux-en-Y Gastric Bypass. Obes Surg 2021; 31: 949-964 DOI: 10.1007/s11695-020-05094-y.
53 Khalaj A, Mousapour P, Motamedi MAK. et al. Comparing the Efficacy and Safety of Roux-en-Y Gastric Bypass with One-Anastomosis Gastric Bypass with a Biliopancreatic Limb of 200 or 160 cm: 1-Year Results of the Tehran Obesity Treatment Study (TOTS). Obes Surg 2020; 30: 3528-3535 DOI: 10.1007/s11695-020-04681-3.
54 Boerboom A, Homan J, Aarts E. et al. A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial. Surg Obes Relat Dis 2019; 15: 60-69 DOI: 10.1016/j.soard.2018.10.010.
55 Smelt HJM, Van Rijn S, Pouwels S. et al. The Influence of Different Alimentary and Biliopancreatic Limb Lengths in Gastric Bypass Patients. Obes Surg 2021; 31: 481-489 DOI: 10.1007/s11695-020-05028-8.
56 Ibrahim MY, Elshennawy AS, Wassef ATS. et al. One Anastomosis Gastric Bypass Versus Long Biliopancreatic Limb Roux-en-Y Gastric Bypass. Obes Surg 2022; 32: 779-785 DOI: 10.1007/s11695-021-05874-0.
57 Bashah M, Aleter A, Baazaoui J. et al. Single Anastomosis Duodeno-ileostomy (SADI-S) Versus One Anastomosis Gastric Bypass (OAGB-MGB) as Revisional Procedures for Patients with Weight Recidivism After Sleeve Gastrectomy: a Comparative Analysis of Efficacy and Outcomes. Obes Surg 2020; 30: 4715-4723 DOI: 10.1007/s11695-020-04933-2.
58 Kermansaravi M, Shahmiri SS, DavarpanahJazi AH. et al. One Anastomosis/Mini-Gastric Bypass (OAGB/MGB) as Revisional Surgery Following Primary Restrictive Bariatric Procedures: a Systematic Review and Meta-Analysis. Obes Surg 2021; 31: 370-383 DOI: 10.1007/s11695-020-05079-x.
59 Topart PA, Becouarn G. Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures. Surg Obes Relat Dis 2015; 11: 965-972 DOI: 10.1016/j.soard.2015.01.015.
60 Khalaf M, Hamed H. Single-Anastomosis Sleeve Ileal (SASI) Bypass: Hopes and Concerns after a Two-Year Follow-up. Obes Surg 2021; 31: 667-674 DOI: 10.1007/s11695-020-04945-y.
61 Emile SH, Mahdy T, Schou C. et al. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity with proportion meta-analysis of improvement in diabetes mellitus. Int J Surg 2021; 92: 106024 DOI: 10.1016/j.ijsu.2021.106024.
62 Gentileschi P, Bianciardi E, Siragusa L. et al. Banded Sleeve Gastrectomy Improves Weight Loss Compared to Nonbanded Sleeve: Midterm Results from a Prospective Randomized Study. J Obes 2020; 2020: 9792518 DOI: 10.1155/2020/9792518.
63 Kraljevic M, Köstler T, Susstrunk J. et al. Revisional Surgery for Insufficient Loss or Regain of Weight After Roux-en-Y Gastric Bypass: Biliopancreatic Limb Length Matters. Obes Surg 2020; 30: 804-811 DOI: 10.1007/s11695-019-04348-8.
64 Gadiot RPM, Biter LU, Feskens PG. et al. Midterm Results from the Dutch Common Channel Trial (DUCATI): Superior Weight Loss Results of the Long Roux Limb Gastric Bypass in Comparison to the Standard Bypass at 3-Year Follow-Up. Obes Surg 2021; 31: 5132-5140 DOI: 10.1007/s11695-021-05690-6.
65 Susstrunk J, Lazaridis II, Köstler T. et al. Long-Term Outcome of Proximal Versus Very-Very Long Limb Roux-en-Y Gastric Bypass: the Roux-Limb to Common Channel Ratio Determines the Long-Term Weight Loss. Obes Surg 2021; 31: 994-1003 DOI: 10.1007/s11695-020-05109-8.
66 Shah K, Nergard BJ, Fagerland MW. et al. Distal gastric bypass: 2-m biliopancreatic limb construction with varying lengths of common channel. Surg Obes Relat Dis 2019; 15: 1520-1526 DOI: 10.1016/j.soard.2019.05.003.
67 Ghiassi S, Higa K, Chang S. et al. Conversion of standard Roux-en-Y gastric bypass to distal bypass for weight loss failure and metabolic syndrome: 3-year follow-up and evolution of technique to reduce nutritional complications. Surg Obes Relat Dis 2018; 14: 554-561 DOI: 10.1016/j.soard.2018.01.004.
68 Wang A, Poliakin L, Sundaresan N. et al. The role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review. Surg Obes Relat Dis 2022; 18: 555-563 DOI: 10.1016/j.soard.2021.08.022.
69 Pencovich N, Lahat G, Goldray O. et al. Safety and Outcome of Laparoscopic Sleeve Gastrectomy Following Removal of Adjustable Gastric Banding: Lessons from 109 Patients in a Single Center and Review of the Literature. Obes Surg 2017; 27: 1266-1270 DOI: 10.1007/s11695-016-2463-y.
70 Gonzalez-Urquijo M, Hinojosa-Gonzalez DE, Gidi AGA. et al. Revisional Roux-en-Y gastric bypass after failed gastric banding: a case-matched study. Surg Endosc 2022; 36: 4815-4820 DOI: 10.1007/s00464-021-08825-z.
71 Faul A, Chevallier JM, Poghosyan T. Dilated Gastric Pouch Resizing for Weight Loss Failure After One Anastomosis Gastric Bypass. Obes Surg 2019; 29: 3406-3409 DOI: 10.1007/s11695-019-03972-8.